Institut Gustave Roussy - Oncologie Médicale

Villejuif

0 studies enrolling now · 2 studies all time

What they study most

Head and Neck Cancer, Ovarian Cancer

Studies at this site

• Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302) — Running, not enrolling
• Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION) — Stopped early